ATE460430T1 - Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper - Google Patents

Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper

Info

Publication number
ATE460430T1
ATE460430T1 AT03772718T AT03772718T ATE460430T1 AT E460430 T1 ATE460430 T1 AT E460430T1 AT 03772718 T AT03772718 T AT 03772718T AT 03772718 T AT03772718 T AT 03772718T AT E460430 T1 ATE460430 T1 AT E460430T1
Authority
AT
Austria
Prior art keywords
human low
kit
antibodies
molecular weight
low molecular
Prior art date
Application number
AT03772718T
Other languages
English (en)
Inventor
Shoji Furusako
Kamon Shirakawa
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Application granted granted Critical
Publication of ATE460430T1 publication Critical patent/ATE460430T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03772718T 2002-11-12 2003-11-12 Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper ATE460430T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002328866 2002-11-12
JP2003330775 2003-09-22
PCT/JP2003/014389 WO2004044005A1 (ja) 2002-11-12 2003-11-12 ヒト低分子量ｃｄ１４測定キットおよび抗体

Publications (1)

Publication Number Publication Date
ATE460430T1 true ATE460430T1 (de) 2010-03-15

Family

ID=32314082

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03772718T ATE460430T1 (de) 2002-11-12 2003-11-12 Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper

Country Status (10)

Country Link
US (2) US7465547B2 (de)
EP (1) EP1571160B1 (de)
JP (1) JP4081489B2 (de)
CN (1) CN100558746C (de)
AT (1) ATE460430T1 (de)
AU (1) AU2003280753A1 (de)
CA (1) CA2506580C (de)
DE (1) DE60331677D1 (de)
ES (1) ES2340266T3 (de)
WO (1) WO2004044005A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608684B2 (en) * 2002-11-12 2009-10-27 Mochida Pharmaceuticals Co., Ltd. Soluble CD14 antigen
ATE460430T1 (de) 2002-11-12 2010-03-15 Mochida Pharm Co Ltd Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
CN1968962B (zh) * 2004-05-11 2013-07-24 持田制药株式会社 新型可溶性cd14抗原
KR101025723B1 (ko) * 2008-07-18 2011-04-04 주식회사 인포피아 광도파로를 포함하는 면역 크로마토그래피 분석 센서 및이를 이용한 측정방법
KR20180118822A (ko) * 2011-01-11 2018-10-31 가부시키가이샤 엘에스아이 메디엔스 패혈증 예후의 예측 방법
US10191038B2 (en) * 2011-03-28 2019-01-29 Lsi Medience Corporation Immunological measuring method and measuring kit for whole blood sample
AU2012256682B2 (en) 2011-05-19 2017-02-02 Mochida Pharmaceutical Co., Ltd. Diagnosis of respiratory tract infectious disease using blood specimens
US9297802B2 (en) 2011-05-19 2016-03-29 Mochida Pharmaceutical Co., Ltd. Diagnosis of respiratory tract infectious diseases using urine specimens
WO2013024798A1 (ja) * 2011-08-12 2013-02-21 三菱化学メディエンス株式会社 術後感染症を診断する方法
JP6445969B2 (ja) * 2013-04-30 2018-12-26 持田製薬株式会社 プレセプシン測定による発熱性好中球減少症の診断
RS62033B1 (sr) 2014-02-26 2021-07-30 Mochida Pharmaceutical Co Ltd Novo antitelo na presepsin
US11117974B2 (en) 2015-08-25 2021-09-14 Mochida Pharmaceutical Co., Ltd. Specifically purified anti-presepsin antibody
US20180206726A1 (en) 2016-12-07 2018-07-26 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
JP2018140961A (ja) * 2017-02-28 2018-09-13 持田製薬株式会社 ビオチン化ｆ１１０６−１３−３抗体、その製造方法及びその用途
US20210138213A1 (en) 2017-03-30 2021-05-13 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device
JP6842168B2 (ja) * 2017-05-12 2021-03-17 国立大学法人東北大学 マイクロ水滴内イムノアッセイ
WO2019246312A1 (en) 2018-06-20 2019-12-26 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immunomodulator
US20230009902A1 (en) 2018-06-20 2023-01-12 Progenity, Inc. Treatment of a disease or condition in a tissue orginating from the endoderm
EP3883635A1 (de) 2018-11-19 2021-09-29 Progenity, Inc. Verfahren und vorrichtungen zur behandlung einer krankheit mit biotherapeutika
WO2021097685A1 (zh) * 2019-11-19 2021-05-27 深圳迈瑞生物医疗电子股份有限公司 混合检测PCT和Presepsin的试剂盒、方法以及应用
CN113939314B (zh) * 2019-11-19 2022-09-30 武汉全景生物技术有限公司 新的抗可溶性cd14亚型抗体及其应用
CN115666704A (zh) 2019-12-13 2023-01-31 比奥拉治疗股份有限公司 用于将治疗剂递送至胃肠道的可摄取装置
WO2023198982A1 (fr) 2022-04-11 2023-10-19 bioMérieux Biomarqueur ptx3 pour la reduction de l'antibiotherapie chez le nouveau-ne
CN114839253A (zh) * 2022-04-21 2022-08-02 深圳市第二人民医院(深圳市转化医学研究院) 血清或血浆中低分子量蛋白定量分析方法及应用
CN116444673B (zh) * 2023-06-14 2023-09-15 北京汇智和源生物技术有限公司 人源膜cd14单克隆抗体及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931385A (en) * 1985-06-24 1990-06-05 Hygeia Sciences, Incorporated Enzyme immunoassays and immunologic reagents
DD286876A5 (de) 1989-08-10 1991-02-07 Ernst-Moritz-Arndt-Universitaet Greifswald,De Verfahren zur bestimmung eines loeslichen humanen monozytenoberflaechenantigens
US5766593A (en) * 1994-12-30 1998-06-16 Amgen Inc. Anti-inflammatory CD14 peptides
DK1140175T3 (da) 1998-12-21 2006-08-14 Ludwig Inst Cancer Res Antistoffer mod trunkeret VEGF-D og anvendelser deraf
US7326568B2 (en) * 1999-02-04 2008-02-05 University Of Georgia Research Foundation, Inc. Recombinant expression of heterologous nucleic acids in protozoa
EP1213586A4 (de) * 1999-09-17 2003-02-05 Mochida Pharm Co Ltd Verfahren zum fraktionierten messen von löslichem cd14-protein
WO2001072993A1 (fr) 2000-03-31 2001-10-04 Mochida Pharmaceutical Co., Ltd. Inhibiteur de liaison entre le recepteur de type toll et cd14
EP1336620A4 (de) 2000-11-22 2004-11-17 Mochida Pharm Co Ltd Monoklonaler, die cd14/tlr-bindung hemmender anti-cd14-antikörper
ATE460430T1 (de) 2002-11-12 2010-03-15 Mochida Pharm Co Ltd Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper

Also Published As

Publication number Publication date
EP1571160B1 (de) 2010-03-10
US7901900B2 (en) 2011-03-08
EP1571160A1 (de) 2005-09-07
CN100558746C (zh) 2009-11-11
ES2340266T3 (es) 2010-06-01
US7465547B2 (en) 2008-12-16
CA2506580C (en) 2010-08-17
JP4081489B2 (ja) 2008-04-23
WO2004044005A1 (ja) 2004-05-27
EP1571160A4 (de) 2007-03-21
US20070106067A1 (en) 2007-05-10
AU2003280753A1 (en) 2004-06-03
CA2506580A1 (en) 2004-05-27
JPWO2004044005A1 (ja) 2006-05-11
US20090029396A1 (en) 2009-01-29
CN1711283A (zh) 2005-12-21
DE60331677D1 (de) 2010-04-22

Similar Documents

Publication Publication Date Title
ATE460430T1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
EP2295465A3 (de) Menschliche monoklonale Antikörper gegen das Influenza M2 Protein sowie Methoden zu deren Herstellung und Verwendung
EP2147928A3 (de) Auf Peptiden basierte Immunisierungstherapie zur Behandlung von Atherosklerose und Entwicklung von Peptid-basierten Assays zur Bestimmung von Immunreaktionen gegen oxidiertes Lipoprotein geringer Dichte
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
EP2343318A3 (de) Antikörper die an ein C-terminales Fragment des Apolipoproteins E binden
WO2004046194A3 (en) Polyclonal-monoclonal elisa assay for detecting n-terminus probnp
HK1099807A1 (en) Method for detecting the formation of endothelins for medical diagnosis, and antibodies and kits for carrying out one such method
NO901899L (no) Hiv-peptider, syntetiske hiv-antigener og immunoanalysekit
RU2009143671A (ru) Высокочувствительные иммуноанализы и наборы для определения представляющих интерес пептидов и белков
ATE474855T1 (de) Polyklonaler-monoklonaler-elisa-assay zum nachweis von n-terminalem probnp
ATE335763T1 (de) Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden
WO2001061305A3 (en) Immunoassays detecting or making use of at least two rubber latexallergens
DE60129239D1 (de) Kit und verfahren zur bestimmung von protein esm-1
WO2006004958A3 (en) Detection or measurement of antibodies to antigenic proteins in biological tissues or samples
DE60219645D1 (de) Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
EP1780215A4 (de) Morbus-crohn-antikörperepitoppeptid und reagens zum testen auf morbus crohn
ES2584982T3 (es) Procedimiento para el diagnóstico de infecciones de bacterias Propionibacterium
WO2004003155A3 (en) Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
CA2505995A1 (en) Cobalamin assay
SG156619A1 (en) Novel cancer associated antibodies and antigens and their use in cancer diagnosis
WO2004065936A3 (en) Immunoglobulin e detection in mammalian species
CA2488127A1 (en) Antibodies directed against prothrombin fragment f1+2, the preparation and use thereof
WO2002046769A3 (en) A monoclonal antibody-based diagnostic assay for gamma fibrinogen
SE8901566D0 (sv) Nya peptider inkluderande en disulfidbindning
JP2004108986A5 (de)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties